Abgenix Enters Exclusive Manufacturing Agreement With Lonza Biologics
30-Jan-2001 -
Abgenix, Inc. (Nasdaq: ABGX) today announced that it has entered into a manufacturing supply agreement with Lonza Biologics
(Lonza) wherein Lonza will make available exclusively to Abgenix, for a period of five years, a cell culture production suite within its facility in Slough, England. The
...
antibodies
cell cultures
clinical trials
+1